SCHEMBL18976359

SCHEMBL18976359

CCC(C)N1CC2(CCOC[C@@H]2N)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18969273 0.83 — —
SCHEMBL18969324 0.83 — —
SCHEMBL23865782 0.79 — —
SCHEMBL23746507 0.77 — —
SCHEMBL24792233 0.76 — —
SCHEMBL22049072 0.75 PTPN11 (0.36) —
SCHEMBL18390359 0.74 — —
SCHEMBL18968111 0.74 — —
SCHEMBL23746508 0.72 JAK2 (0.34) —
SCHEMBL22778770 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963448-B2 Bicyclic inhibitors of PAD4 PADLOCK THERAPEUTICS, INC. (US) 2018-05-08 — — US disclosed
US-20170166565-A1 BICYCLIC INHIBITORS OF PAD4 PADLOCK THERAPEUTICS, INC. 2017-06-15 — — US disclosed
Send feedback